 Second, complex multilevel structural interventions are expensive. Typically, non-governmental organizations NGOs, or government agencies implement them. The cost and complexity of study designs that would adequately evaluate real-world structural interventions do not align well with the typical NIH-funded randomized control trial RCT model; this presumably could explain the dearth of research. 